FDA Import Refusal AEK-2337988-4/21/1 — Eli Lilly
The FDA refused shipment AEK-2337988-4/21/1 from Eli Lilly (United States) on Dec 9, 2022. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 9, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75